iRadimed
IRMD • NASDAQ
iRadimed is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Roger E. Susi, with a market cap of $1.2B.
CEORoger E. Susi
Next Earnings
Upcoming earnings announcement for iRadimed
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.43
Revenue Estimate
$21.4M
Earnings History
Past 12 earnings reports for iRadimed
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $0.54Est: $0.46 | +17.4% | $22.7MEst: $21.7M | +4.7% |  10-K |
| Nov 3, 2025 | Q3 2025 | $0.47Est: $0.45 | +4.4% | $21.2MEst: $20.5M | +3.4% | 10-Q |
| Aug 1, 2025 | Q2 2025 | $0.49Est: $0.43 | +14.0% | $20.4MEst: $20.1M | +1.4% | 10-Q |
| May 5, 2025 | Q1 2025 | $0.42Est: $0.41 | +2.4% | $19.5MEst: $19.3M | +0.9% | 10-Q |
| Feb 13, 2025 | Q4 2024 | $0.44Est: $0.44 | 0.0% | $19.4MEst: $19.2M | +1.0% | 10-K |
| Oct 31, 2024 | Q3 2024 | $0.43Est: $0.38 | +13.2% | $18.3MEst: $18.1M | +1.2% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $0.42Est: $0.36 | +16.7% | $17.9MEst: $17.7M | +1.6% | 10-Q |
| May 2, 2024 | Q1 2024 | $0.36Est: $0.33 | +9.1% | $17.6MEst: $17.1M | +2.7% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $0.39Est: $0.40 | -2.5% | $17.5MEst: $17.3M | +0.7% | 10-K |
| Nov 3, 2023 | Q3 2023 | $0.43Est: $0.36 | +19.4% | $16.5MEst: $16.2M | +2.1% | — |
| Aug 3, 2023 | Q2 2023 | $0.36Est: $0.31 | +16.1% | $16.1MEst: $15.7M | +3.1% | — |
| May 4, 2023 | Q1 2023 | $0.30Est: $0.28 | +7.1% | $15.5MEst: $14.8M | +4.8% | — |